🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: placebo matched for fluticasone propionate

Found 38 matching trials

A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) Rhinitis

PHASE2

The purpose of this pilot study is to compare the effects (effectiveness an...

Status

Completed

Location

GSK Investigational Site

Start Date

2008-03

Trial ID

NCT00730756

Treatments Being Tested

Fluticasone Furoate Nasal Spray Placebo Nasal Spray

Add-on Dupilumab for AFRS as Postoperative Therapy (ADAPT)

PHASE3

The purpose of this study is to find a more effective treatment for allergi...

Status

Terminated

Location

Emory Hospital Midtown-Otolaryngology

Start Date

2023-10-26

Trial ID

NCT05545072

Treatments Being Tested

Dupilumab Placebo Intranasal Corticosteroid Sprays (INCS)

Relovair PD PK in Chinese Healthy Subjects

PHASE1

In this study, fluticasone furoate (FF) and vilanterol (VI) in different do...

Status

Completed

Location

GSK Investigational Site

Start Date

2012-12-05

Trial ID

NCT01711463

Treatments Being Tested

Fluticasone Furoate/Vilanterol Placebo

Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED)

PHASE3

This purpose of this study is to determine the efficacy and safety of a gra...

Status

Completed

Location

Multiple Locations

Start Date

2007-11

Trial ID

NCT00562159

Treatments Being Tested

Placebo SCH 697243 Loratadine 10 mg Rescue Treatment Olopatadine 0.1% Rescue Treatment Mometasone 50 mcg Rescue Treatment Prednisone 5 mg Rescue Treatment Albuterol sulfate 108 mcg Fluticasone propionate 44 mcg Prednisone 5 mg

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

PHASE4

The primary purpose of this study is to evaluate lung function and health r...

Status

Completed

Location

GSK Investigational Site

Start Date

2018-06-25

Trial ID

NCT03478696

Treatments Being Tested

budesonide/formoterol albuterol/salbutamol FF/UMEC/VI Placebo to match budesonide/formoterol tiotropium Placebo to match FF/UMEC/VI placebo to match tiotropium ELLIPTA MDI HandiHaler

Study to Compare the Addition of Umeclidinium Bromide (UMEC) to Fluticasone Furoate (FF)/Vilanterol (VI), With Placebo Plus FF/VI in Subjects With Chronic Obstructive Pulmonary Disease (COPD) -Study 2

PHASE3

After screening, subjects will enter a 4 week open-label run-in period with...

Status

Completed

Location

GSK Investigational Site

Start Date

2013-10

Trial ID

NCT02119286

Treatments Being Tested

FF VI UMEC Placebo

Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED)

PHASE3

The purpose of the study is to investigate the efficacy and safety of a gra...

Status

Completed

Location

Multiple Locations

Start Date

2007-11

Trial ID

NCT00550550

Treatments Being Tested

Placebo SCH 697243 Loratadine Syrup 1 mg/mL Rescue Treatment Loratadine 10 mg Rescue Treatment Olopatadine 0.1% Rescue Treatment Mometasone furoate 50 mcg Rescue Treatment Albuterol 108 mcg Rescue Treatment Fluticasone 44 mcg Rescue Treatment Prednisone 5 mg Rescue Treatment

A Study in Patients With Chronic Obstructive Pulmonary Disease

PHASE3

The primary objective of the study was to demonstrate the superiority of Fo...

Status

Completed

Location

Aarhus University Hospital

Start Date

2011-04-12

Trial ID

NCT01245569

Treatments Being Tested

Beclomethasone Dipropionate - Formoterol Fluticasone - Salmeterol

Evaluation of Tolerability and Pharmacokinetics of Roflumilast, 250μg and 500μg, as add-on to Standard COPD Treatment to Treat Severe COPD

PHASE3

The purpose of this study is to evaluate discontinuation rates of roflumila...

Status

Completed

Location

Multiple Locations

Start Date

2014-05-01

Trial ID

NCT02165826

Treatments Being Tested

Roflumilast Roflumilast Placebo Standard of Care COPD Treatment

Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler

PHASE3

This study is to evaluate the safety and efficacy of fluticasone propionate...

Status

Completed

Location

Teva Investigational Site 13881

Start Date

2016-12-28

Trial ID

NCT02980133

Treatments Being Tested

Fluticasone Propionate Fluticasone Propionate/Salmeterol Placebo MDPI

Previous Next